CN118202043A - 具有多价作用的肽 - Google Patents

具有多价作用的肽 Download PDF

Info

Publication number
CN118202043A
CN118202043A CN202280070606.5A CN202280070606A CN118202043A CN 118202043 A CN118202043 A CN 118202043A CN 202280070606 A CN202280070606 A CN 202280070606A CN 118202043 A CN118202043 A CN 118202043A
Authority
CN
China
Prior art keywords
peptide
amino acids
seq
peptides
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280070606.5A
Other languages
English (en)
Chinese (zh)
Inventor
A·施米特兴
G·彼得鲁克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yingtuku Co
Original Assignee
Yingtuku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yingtuku Co filed Critical Yingtuku Co
Publication of CN118202043A publication Critical patent/CN118202043A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202280070606.5A 2021-10-22 2022-10-21 具有多价作用的肽 Pending CN118202043A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21204274.1 2021-10-22
EP21204274 2021-10-22
PCT/EP2022/079429 WO2023067167A1 (en) 2021-10-22 2022-10-21 Peptides with multivalent effects

Publications (1)

Publication Number Publication Date
CN118202043A true CN118202043A (zh) 2024-06-14

Family

ID=78592450

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280070606.5A Pending CN118202043A (zh) 2021-10-22 2022-10-21 具有多价作用的肽

Country Status (7)

Country Link
US (1) US20250313820A1 (enExample)
EP (1) EP4419664A1 (enExample)
JP (1) JP2024539138A (enExample)
CN (1) CN118202043A (enExample)
AU (1) AU2022369065A1 (enExample)
CA (1) CA3233135A1 (enExample)
WO (1) WO2023067167A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024223868A1 (en) * 2023-04-26 2024-10-31 In2Cure Ab Peptides with multivalent effects for topical use
WO2025051955A1 (en) 2023-09-06 2025-03-13 In2Cure Ab Materials with anti-inflammatory and/or anti-microbial properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987056B1 (en) * 2006-02-10 2012-07-25 Dermagen AB Novel antimicrobial peptides and use thereof
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
JP7785001B2 (ja) * 2019-12-18 2025-12-12 イントゥーキュア エービー トロンビン由来ペプチドを含む組成物およびその使用

Also Published As

Publication number Publication date
US20250313820A1 (en) 2025-10-09
JP2024539138A (ja) 2024-10-28
AU2022369065A1 (en) 2024-04-11
WO2023067167A1 (en) 2023-04-27
CA3233135A1 (en) 2023-04-27
EP4419664A1 (en) 2024-08-28

Similar Documents

Publication Publication Date Title
RU2468033C2 (ru) Антибактериальные пептиды
CA2341340C (en) Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
KR102137941B1 (ko) 항균 펩티드
CN114341160B (zh) 包含赖氨酸替换的romo1来源抗微生物肽及其变体
JP2012041367A (ja) 抗菌性カチオン性ペプチドおよびそれらの処方物
WO2011036443A2 (en) Polypeptides and uses thereof
KR20090027213A (ko) 개선된 항미생물성 펩타이드
WO2015161820A1 (zh) 两亲性合成抗菌肽、其药物组合物及其用途
CN118202043A (zh) 具有多价作用的肽
JPH01206992A (ja) 塩基性蛋白、その誘導体およびフラグメント、ならびにそれらの用途
Cui et al. Preparation, characterization and pharmacokinetic study of N-terminal PEGylated D-form antimicrobial peptide OM19r-8
CN117586352B (zh) 一种基于宽体金线蛭唾液腺的抗菌多肽aph220及其应用
JP4812347B2 (ja) 抗菌性ペプチド
CN107474116A (zh) 抗菌肽msi‑1及其用途
WO2006127715A1 (en) Antimicrobial peptides
AU2017426938B2 (en) Disintegrin variants and uses thereof
CN114989246A (zh) Fk3多肽类似物及其应用
CN108752433B (zh) 抗微生物肽cramp及其环肽在制备清除细菌生物膜的药物中的应用
Porta et al. Myotoxin a, crotamine and defensin homologs in reptile venoms
CN115960163A (zh) 抗菌肽、包含抗菌肽的药物组合物及其应用
KR20030077950A (ko) 생리활성 복합체
JP3645282B2 (ja) ヘパリン中和剤
CN121574193A (zh) 基于fk3的碳硼烷偶联肽及其制备方法和应用
CN118460518A (zh) 一种多肽及其用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination